Adage Capital Partners
AMED

Adage Capital Partners’s Amedisys AMED Stock Holding History

Adage Capital Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-103,233
Closed -$10.2M – 879
2025
Q2 		$10.2M Sell
103,233
-346,989
-77% -$32.8M 0.02% 615
2025
Q1 		$41.7M Buy
450,222
+32,220
+8% +$2.97M 0.08% 259
2024
Q4 		$38M Buy
418,002
+102,099
+32% +$9.38M 0.07% 276
2024
Q3 		$30.5M Buy
315,903
+273,239
+640% +$26.7M 0.05% 337
2024
Q2 		$3.92M Buy
+42,664
New +$3.96M 0.01% 735
2023
Q3 		– Sell
-76,394
Closed -$6.99M – 869
2023
Q2 		$6.99M Buy
+76,394
New +$6.27M 0.02% 625
2017
Q3 		– Sell
-350,000
Closed -$22M – 709
2017
Q2 		$22M Hold
350,000
– – 0.05% 395
2017
Q1 		$17.9M Buy
350,000
+50,000
+17% +$2.38M 0.05% 427
2016
Q4 		$12.8M Buy
+300,000
New +$12.8M 0.03% 481
2016
Q2 		– Sell
-100,000
Closed -$4.83M – 684
2016
Q1 		$4.83M Buy
+100,000
New +$3.86M 0.01% 609
2015
Q4 		– Sell
-50,000
Closed -$1.9M – 688
2015
Q3 		$1.9M Sell
50,000
-150,000
-75% -$6.33M 0.01% 677
2015
Q2 		$7.95M Buy
+200,000
New +$6.23M 0.02% 580
2013
Q3 		– Sell
-840,534
Closed -$9.75M – 681
2013
Q2 		$9.75M Buy
+840,534
New +$9.63M 0.03% 507

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Adage Capital Partners's AMED Position: Q3 2025 in Review

Adage Capital Partners sold out of Amedisys (AMED) in Q3 2025, closing a stake of 103,233 shares — an estimated $10.2M sold.

Adage Capital Partners first reported a position in AMED in Q2 2013 and held it in 13 quarters. The position peaked at $41.7M in Q1 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Adage Capital Partners reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Adage Capital Partners sold 103,233 Amedisys shares in Q3 2025, an estimated $10.2M.
  • Adage Capital Partners first reported a position in Amedisys in Q2 2013 and held it in 13 quarters.
  • Adage Capital Partners's Amedisys position peaked at $41.7M in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Adage Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.